Page 2 - SISTECH Brochure - UPH 2022
P. 2

  MRIN-UPH Participates Globally in Sending Coronavirus Genome Data to ‘GISAID’
Mochtar Riady Institute for Nanotechnology-Universitas Pelita Harapan (MRIN-UPH) has actively participated in global research on the spread of coronavirus in Indonesia by sending samples of viral DNA sequences from Indonesian Covid-19 patients to GISAID
(Global Initiative on Sharing All Influenza Data). Established in 2006, MRIN-UPH is the only private research institution in Indonesia to send genomes to GISAID. Although MRIN UPH initially focused on cancer research, it has quickly responded to the current pandemic by conducting research on the coronavirus. So far, it has sent 17 sequences to GISAID, the first time in May 2020 and second time in January 2021. Read more
MRIN-UPH And Eijkman Signed a Partnership Agreement for the Whole Genome Sequencing of the Sars-Cov-2 Virus
Mochtar Riady Institute for Nanotechnology-Universitas Pelita Harapan (“MRIN-UPH”) officially signed a partnership agreement with the Eijkman Institute for Molecular Biology (“Eijkman”), a research institution under Indonesia’s Ministry of Research and
Technology on Thursday, April 29, 2021. The collaboration between Eijkman and MRIN-UPH involves Whole Genome Sequencing (WGS) of the SARS-COV-2 virus, which is responsible for Covid-19. MRIN-UPH became the first private research institution to cooperate with Eijkman in the WGS SARS-CoV-2 project.
This agreement was signed by Prof. dr. Irawan Yusuf, Ph.D., President of Mochtar Riady Nanotechnology Institute and Prof. dr. David H. Muljono, Sp.PD., FINASIM, Ph.D., Deputy Head of Eijkman Institute, with Dr. rer. nat. Ivet Suriapranata, Head of MRIN-UPH’s Research Division, and Drh. Safarina G. Malik, M.S., Ph.D., Chief Secretary of Eijkman Institute, as witnesses. Read more
   2
 


























































































   1   2   3